Laura Pardo

Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group

Michael R. Loken, Todd A. Alonzo, Laura Pardo et al. · Blood · 2012 · 293 citations · Full text

Medicine, Hematology, Oncology +17

<i>CEBPA</i>-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children’s Oncology Group

Katherine Tarlock, Adam J. Lamble, Yi‐Cheng Wang et al. · Blood · 2021 · 120 citations · Full text

Medicine, Hematology, Oncology +7

Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer

Cristina Valero, Laura Pardo, Montserrat López et al. · Head & Neck · 2016 · 94 citations

Medicine, Oncology, Cancer Epidemiology +11

Comprehensive Transcriptome Profiling of Cryptic <i>CBFA2T3–GLIS2</i> Fusion–Positive AML Defines Novel Therapeutic Options: A COG and TARGET Pediatric AML Study

Jenny L. Smith, Rhonda E. Ries, Tiffany Hylkema et al. · Clinical Cancer Research · 2019 · 76 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +14

Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma

Cristina Valero, Laura Pardo, Aina Sansa et al. · Head & Neck · 2019 · 75 citations

Medicine, Immunology, Oncology +17